PrintThe Burrill Report
The Burrill Report (July 28, 2014): Breaking through the Sequencing Bottleneck (.MP3,15.54 Mb)
The rapid decline in the cost of genome sequencing is creating an information technology bottleneck as servers designed for general purposes have proven a bit clunky at assembling and analyzing the output from sequencers. Edico Genome thinks it has an answer with its DRAGEN Bio-IT Processor, designed specifically for processing genomic data. We spoke to Pieter van Rooyen, CEO of Edico about tackling the computing bottleneck, how the company plans to use the $10 million in funding it just raised, and what the implications of a dramatic reduction in time and cost will have on how sequencing is used.
July 22, 2014
http://www.burrillreport.com/article-breaking_through_the_sequencing_bottleneck_.html
INFORMATION TECHNOLOGY
Breaking through the Sequencing Bottleneck
Podcast: July 28, 2014[Please login to post comments]
- U.S. Government’s Effort to Quell Tax-Driven Acquisitions Could Slow Life Sciences Dealmaking
Nearly half of dollar volume of M&A; activity in 2014 involved inversions, says Burrill Media Read More - Life Sciences M&A; Activity Sets Annual Record with $8.3B Roche Agreement to buy Intermune, Burrill Media Reports
Press Release Read More - Fitness and Personal Health Apps Could Pose Privacy Nightmare
Senator Schumer says patients’ data could be sold to third parties without their knowledge. Read More - Intel and Fox Foundation Team to Use Smartwatches to Track Parkinson's Patients
Data from wearable devices has potential to improve monitoring and treatment. Read More - Otonomy Raises $100M in Upsized IPO
Seventy-seven life sciences companies raised $5.8 billion through IPOs by mid-August. Read More - Payers Look to Curb Spending on Specialty Drugs
Podcast: August 18, 2014 Read More - Sanofi Licenses Rights to MannKind’s Afrezza for Up to $925M
After many years of struggling, biotech lands marketing partner for inhaled insulin. Read More - New System for Classifying Cancer Could Change the Way Drugs Are Developed
Largest cancer genetic analysis reveals tumor subtype correlated to cell type rather than tissue type. Read More - Juno Therapeutics Fills Its Coffers with Another $134M
Funding for the biotech startup in hot CAR T-cell therapy space tops $300 million. Read More - Cerner Buys Siemens Health Services for $1.3B
Deal creates scale for future innovation, moving company beyond electronic medical records. Read More
